  

I personally mformed t IS atient t at a spe01men s wou

purposes. I reviewed the RESEARCH SUBJECT INFORMATION AND CONSENT
FORM'with the patient and answered any questions the patient had. The patient then signed the
cons-ent'form as a free and voluntary act. A copy of this informed consent document will be retained at

 

 

 

 

   

 

    

Chief cam‘p‘taintss

 

Eel"? £3330”: ﬁﬂé’ﬁi t3: wt “h
I . s g
' ’ e ‘ M a ‘ ,t, »
Symptoms. 3%, W Wig/k $1,, ‘ {>5

 

Clinical Findings:

 

Performance Scale (Karnofsky Score): 6M“
El 100 Asymptomatic El 80-90 Symptomatic but Fully Ambulatory Ewwﬁymptomaﬁc, in bed less than 50% of day

B 40-50 Symptomatic, in bed more than 50% of day, but not bed ridden a 20-30 Bed Ridden

 

 

 

Route

 

.... PAST-MEDICALHISTORY- . _. _.
Disease Disorder Date Treatment Status

Environmental Hazards:

Smoki H
Current Packs Duration
El YES NO

Alcohol Consum
Current Status TYPE Drinks Duration
El YES 0

D Use

Current Duration
El YES NO

Relative

Result
[:1 N D Positive:
H B [I Positive: E] N ve D Positive:
H C N El Positive: Cl N ve a Positive:
AFP El ve [3 Positive: El N ve El Positive:
Other:

D Negative El Positive: [3 Negative [:1 Positive:

B/T Cell Markers

 

 
  

Ultrasound
X—Ra
CT

 
     
  

  
  
 

End
MRI
Bio

  

Clinical
Location of Involved L Nodes Location of Distant Metastasis

Clinical
T Z N M [3} Stage: (1?;

 

 

l1" reatment Informaticﬁ

Procedure

Prima mor
Detailed Location

Extension of Tumor

L Nodes
Location of L Nodes # of L Nodes

Palpable, Non-Dissected Lymph Nodes
Dissected Lymph Nodes

Distant Metastasis
Detailed Location

reatment Route

 

  

Pathology For

 

{Specimen Informationl

 

‘ Frozen Parafﬁn Block Blood/Serum/Plasma Slide
Diseased Normal Diseased Normal Diseased Normal Diseased Normal

2,. ‘2
e to LN2 me to Formalin Time to LN2

Prima Tumor
Size Extension of Tumor Distance to NAT

37 X Cm cm

h Nodes
Location # Examined # Metastasized

Distant Metastasis
Detailed Location

Patho ical in
p12 N Ma Stage: 3':
Notes: ,

€57o/Wz7 e; 457247048 {i 2,, M4345; z}? Ng‘iéé’yﬁﬂza >

aaaﬁmz‘ggﬂ ééz-aféssgas t franks/m 1/)

 

 

[Microscopic Description!

 

Cell Distribution Structural Pattern
Diffuse Stream
Mosaic Storiform
Necrosis Fibrosis
L Infiltration Palisad
Vascular Invasion C
Clusterized

Alveolar Formation
Indian File Calciﬁcation

mous + - Adenomatous + - Sarcomatous + - L
Cell Glandular cell V Round Cell La Cell
le Cell Cell Stratiﬁcation Fibroblast Small Cell
Keratin Secretion Osteoblast RS RS Like
Desmosome Vacuole Inflam. Cell
Pearl Gland formation Plasma Cell
Cellular Differentiation: Well Moderate Poor

Nuclear II

Aniso Nucleosis
romatism
Nucleolar Prominent
Multinucleated Giant Cell
Mitotic
Nuclear Grade:

Marker Result
ER 've El Positive

PR ve DPositive
Her- neu DPositive

B-Cell Marker El Positive

T—Cell Marker ' a Positive
Other: ' El Positive

Other: ' El Positive

 

 

lFinal Pathokm Reporli

x. “,3 it . ,, ‘ g 1
Aa/éﬂﬂﬁﬂPC/xj/‘2m/l / PM??? /4/ ﬂiW/Q'Zﬂ /4"/§\/ /
i j ‘J ' Grade: neg

Histological Diagnosis:

 

I. Hism‘lggiial pattern:

 

 

CELL DISTRIBUTION

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

. ' + - STRUCTURAL PATTERN
Diffuse a; Stream"
Mosaic 453/ Storiform
Necrosis ”Oi Fibrosis
L mphocytic Inﬁltration R $ Palisadﬂg
Vascular invasion y Cystic Diggmmﬁon
Clusterized Bleedirg
Alveolar Formation 0’ Myxoid Change
lndian File a? Psammoma/Calciﬁcation

2. Cellular features:

Squamous + - Adenomatous + - Sarcomatous + Lymphomatous
Squamoid Cell Glandular cell 5)" Round Cell Large Cell
Spindle Cell Cell Stratiﬁcation if Fibroblast Small Cell .
Keratin Secretion i Osteoblast RS Cell/RS Like
Desmosome lntracyt. Vacuole :2 Lipoblast lnﬂam Ce"
Pearl Gland formation Myoblast Plasma Cell
Otherwise Speciﬁed:

5 Wat/Piaf: AMP: AMP7

 

 

2. Cellular Drﬂ‘erentiation.

3. Nuclear

 

Aniso

 

Well

Moderately

 

Poor

 

 

 

 

 

Multinucleated Giant Cell

Mitotic

Histological Diagnosis:

Nuclear Grade

M

\

PPWMﬂPc/PAW 5~§
[Pads/LN PMPPW‘PC’Q-sa/f‘é W

  
 

